Balancing Industry and Drug Policy Objectives in the Pharmaceutical Sector: The Case of China.

Chen, Piao-Piao; Yuan, Can-Can; Hu, Yu-Qi; Pei, Pei; Jia, Shuai-Qi; Wang, En-Nan; Xi, Xiao-Yu

Chen, Piao-Piao; Yuan, Can-Can; Hu, Yu-Qi; Pei, Pei; Jia, Shuai-Qi; Wang, En-Nan; Xi, Xiao-Yu.

Afiliación

Chen PP; 1 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Yuan CC; 1 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Hu YQ; 1 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Pei P; 1 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Jia SQ; 1 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Wang EN; 1 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Xi XY; 1 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.

Int Q Community Health Educ ; 37(1): 71-76, 2016 Oct.

Article en En | MEDLINE | ID: mdl-30238857

Palabras clave

China; drug policy; industrial policy; pharmaceutical sector; public health benefits

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int Q Community Health Educ Año: 2016 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google